7th POSTGRADUATE SYMPOSIUM



Similar documents
Interdisciplinary Center for Clinical Research (IZKF), University Hospital Jena

Interdisciplinary Center for Clinical Research (IZKF), University Hospital Jena

16 TH -17 TH INNOVATIONS IN ONCOLOGY NOVEMBER HEIDELBERG

Programme. Michele Grieco Dipartimento di Scienze Ambientali Seconda Università degli Studi di Napoli Naples, Italy

Future Oncology: Technology, Products, Market and Service Opportunities

Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle

Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Biochemistry

Cell Culture Days 2015

American Cancer Society Extramural Grants

Version Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen

Fulfilling the Promise

Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Microbiology, Immunology and Serology

Future Directions in Cancer Research What does is mean for medical physicists and AAPM?

Cancer SBL101. James Gomes School of Biological Sciences Indian Institute of Technology Delhi

TABLE OF CONTENTS. Introduction...1. Chapter1 AdvancesinTreatment...2. Chapter2 MedicinesinDevelopment Chapter3 ValueandSpending...

Department of BioScience Technology Chung Yuan Christian University 2015/08/13

1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1

Midwinter Conference 2015 January Seefeld, Tyrol CONFERENCE PROGRAM. midwinter2015.org. Sponsored by

Understanding the Molecular and Cellular Biology of Endocrine-Related Cancers. Mont Ste. Odile, Alsace, France September 2008

A Career in Pediatric Hematology-Oncology? Think About It...

QUANTITATIVE APPROACHES IN CELL BIOLOGY BIOPHYSICS, BIOENGINEERING & SYSTEMS BIOLOGY

treatments) worked by killing cancerous cells using chemo or radiotherapy. While these techniques can

Advancesincancer immunologyand immunotherapy. announcement. October2015. Royal Olympic Hotel Athens

From Immunotherapy of Cancer to the Discovery of Kidney Cancer Genes

A disease of populations of cells that live, divide, invade and spread without regard to normal limits

MULTIPLE MYELOMA. Dr Malkit S Riyat. MBChB, FRCPath(UK) Consultant Haematologist

American Cancer Society Extramural Grants

TEXT PICTURE. Martin Puhr PhD. Medical University of Innsbruck. Department of Urology Division of Experimental Urology

Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine

Biofocus Molecular Diagnostic Panel

NOVEL PLATFORMS FOR CANCER DIAGNOSIS

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America

Fragment-based lead generation of reversible inhibitors for lysine-specific demethylases

What is Cancer? Cancer is a genetic disease: Cancer typically involves a change in gene expression/function:

LCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH

Cellular, Molecular, and Biochemical Targets in Breast Cancer

What is New in Oncology. Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals

MDC CareerDay April 16, 2015 PROGRAM

2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)

Project ideas of University of Udine for Horizon 2020 Health 2014/2015

Report series: General cancer information

Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer Drugs

Master of Philosophy (MPhil) and Doctor of Philosophy (PhD) Programs in Life Science

Investigating Community Cancer Concerns--Deer Park Community Advisory Council, 2008

FACULTY OF ALLIED HEALTH SCIENCES

Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used?

Cancer. 9p21.3 deletion. t(12;21) t(15;17)

New strategies in anticancer therapy

2 Year ( ) CLL/SLL Research Initiative CLL/SLL Collaborative Grant

Notch 1 -dependent regulation of cell fate in colorectal cancer

Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma

Foundations of Oncology Nursing Practice

Estimated New Cases of Leukemia, Lymphoma, Myeloma 2014

Wadsworth Center. New York State Department of Health. The New Faces BMS

Your Certified Professional Cancer Coach. An Integrative Answer to Cancer Exclusive Professional Program for Patients with Cancer

The Postgraduate Course Toxicology Vienna

International Conference of the Korean Society for Molecular and Cellular Biology

Targeted Therapies in Lung Cancer

Genetic Testing for Hereditary Breast and Ovarian Cancer - BRCA1/2 ANALYSIS -

Types of Cancers [-oma growth ]!

Predictive Biomarkers for PD1 Pathway Inhibitor Immunotherapy

Identification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1

Big Data in Medicine

Developments in Biomarker Identification and Validation for Lung Cancer

Leukemias and Lymphomas: A primer

Subproject 4: Specification and Documentation of Metabolic and Neoplastic Diseases

SECOND PRIMARY BREAST CANCERS FOLLOWING HAEMATOLOGIC MALIGNANCIES A CASE SERIES STUDY FARAH TANVEER PGY 3 DR.MEIR WETZLER DR.

FASEB Directory of Members Online

Targeted Therapeutics Propelling Discovery through Genomic Data

Complex Systems BioMedicine: Molecules, Signals, Networks, Diseases

Course Curriculum for Master Degree in Medical Laboratory Sciences/Hematology and Blood Banking

Biostatistics Credit Integrated and Interdisciplinary Training 2/7 Credit

Cancerfondens planeringsgrupp för Onkologisk Nuklidterapi meeting November 2015

Malignant Lymphomas and Plasma Cell Myeloma

1. Program Title Master of Science Program in Biochemistry (International Program)

Wissenschaftliche Highlights der GSF 2007

Regulation of Protein Translation and c-jun expression by Prostate Tumor Overexpressed1 (PTOV1)

INTERNATIONAL COURSE:

INSERM/ A. Bernheim. Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance

THE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHNS HOPKINS

Future Directions in Clinical Research. Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center

Exelixis Showcases R&D Pipeline at JPMorgan Healthcare Conference

How To Learn More About Melanoma

FINAL AND PERMANENT VERSION THURSDAY, FEBRUARY 17, 2011 DAY 1 (FRIDAY, MAY 6, 2011): Chairpersons: E. Özer (TR) - S.A.Raptis (GR)

Master BioMedical Sciences (BMS) Track Cell Biology and Advanced Microscopy

One out of every two men and one out of every three women will have some type of cancer at some point during their lifetime. 3

LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials

DFG. DFG Hinterzartener Kreis für Krebsforschung. From Molecular Mechanisms to Cancer Therapy

Transcription:

Institute of Pathology In cooperation with:»» Leibniz Institute for Age Research (Fritz Lipmann Institute) IZKF Graduate Program for Experimental Medicine»» Leibniz Institute for Natural Products and Infection Biology Jena (Hans-Knöll-Institute) 7th POSTGRADUATE SYMPOSIUM ON CANCER RESEARCH Saturday, April 25, 2015 Altes Schloss Dornburg (Kaisersaal) 1

ORGANIZATION Institute of Pathology, Jena University in collaboration with» Interdisciplinary Center for Clinical Research (IZKF) Graduate Program for Experimental Medicine, University Jena» UniversitätsTumorCentrum (UTC) Jena» Leibniz Institute for Age Research (Fritz Lipmann Institute)» Leibniz Institute for Natural Products and Infection Biology Jena (Hans-Knöll-Institute)» Jena School of Molecular Medicine» Jena Graduate Academy Prof. Dr. Iver Petersen, Prof. Dr. Alexander Berndt Phone: +49-(3641)-934002 Email: izkfonkologie@med.uni-jena.de SCIENTIFIC COMMITEE Backsch, Claudia Häfner, Norman Baniahmad, Aria Heller, Regine Beck, James Friderich Hilger, Ingrid Berndt, Alexander Hochhaus, Andreas Berndt, Angela Huber, Otmar Böhmer, Frank-Dietmar Liehr, Thomas Chen, Yuan Markert, Udo Clement, Joachim H. Melle, Christian Dürst, Matthias Petersen, Iver Englert, Christoph Popp, Jürgen Ewald, Christian Schulz, Stefan Franz, Marcus Stallmach, Andreas Friedrich, Karlheinz Wang, Zhao-Qi Guntinas-Lichius, Orlando Weigand, Wolfgang Hansel, Alfred 2

LOCATION Kaisersaal, Altes Schloss Dornburg TRAVELLING By train: Take the regional train from Jena-Paradies to Dornburg (Saale). See following link to check the schedule: http://vmt.hafas.de By car (from Jena): Caution: the street lead to Altes Schloss Dornburg is now under construction. Please take the alternate detour route. Give (Jena to:50.9632459,11.5966081 to:51.0022176,11.6193937 to:dornburg/saale) to your navigation or Google Map (Schloßplatz, 07778 Camburg, Germany) Das Symposium ist als ärztliche Fortbildungsveranstaltung im Rahmen des Fortbildungszertifikats der Landesärztekammer Thüringen anerkannt (Kategorie A, Punkte 9). 3

THIS SYMPOSIUM IS SUPPORTED BY: Boehringer Ingelheim Pharma GmbH & Co. KG....(with 500 ) Carl Zeiss Jena GmbH...(with 750 ) Dako Deutschland GmbH...(with 500 ) Lilly Deutschland GmbH...(with 750 ) Merck Serono GmbH...(with 500 ) Novartis Pharma GmbH...(with 1250 ) QIAGEN GmbH... (with symposium materials) Roche Pharma AG...(with 1000 ) Zytomed systems GmbH....(with 500 ) ZytoVision GmbH....(with 500 ) 4

PROGRAM 8:00 Registration 9:00 Welcome address Prof. Dr. O. Guntinas-Lichius, Vice Dean of Study Affairs of the Medical Faculty of the Friedrich Schiller University of Jena 9:10 JIP Cancer Graduation Award Introduction Prof. Dr. Andreas Hochhaus, Director of the Department for Internal Medicine II, Jena University ; Vice-dean for Research of Medical Faculty of FSU; Director of the UniversitätsTumorCentrum Jena Lecture of the laureate 9:30 Keynote lecture Prof. W.W. Franke (Helmholtz Group for Cell Biology, German Cancer Research Center DKFZ): Molecular Diagnostics: Immunocytochemistry using cytoskeletal and junctional cell type markers 10:30 Coffee break 11:00 ORAL PRESENTATIONS SESSION 1: TUMOR CELL BIOLOGY Chairs: Frank Böhmer, Daniel Kritsch 1 Inhibitor of Growth 2 Inhibits Androgen Receptor Signaling in Prostate Cancer Cells Pungsrinont, Thanakorn; Institute of Human Genetics, Jena University 2 Androgen-dependent regulation of long non-coding RNAs in prostate cancer Maiwald, Caroline; Institute of Human Genetics, Jena University 3 Androgen receptor-dependent regulation of htert Kacal, Merve; Institute of Human Genetics, Jena University 5

4 AR-dependent regulation of genes involved in epithelial-mesenchymal transition in prostate cancer cells Colditz, Juliane; Institute of Human Genetics, Jena University 5 Protein tyrosine phosphatase expression analysis in chronic myeloid leukemia (CML)- patient samples and cell lines Drube, Julia; Institute of Molecular Biology, Jena University 6 Bidirectional HGF/c-Met signalling in the bladder cancer microenvironment Jennek, Susanne; Institute of Biochemistry II, Jena University 7 A ChIP-Seq and microarray based approach identifies Wt1 target gene Dong, Lihua; Molecular Genetics, Leibniz Institute for Age Research- Fritz Lipmann Institute (FLI) 8 MCPH1 acts as a modulator of βtrcp2 to regulate mitotic entry Liu, Xiaoqian; Leibniz Institute for Age Research - Fritz Lipmann Institute (FLI) 13:00 Lunch Snack 13:45 POSTER SESSION 1: TUMOR CELL BIOLOGY Chairs: Regine Heller, Joachim Clement 9 The DNA damage independent function of NBS1 in brain development Wang, Pei; Leibniz Institute for Age Research - Fritz Lipmann Institute (FLI) 10 DNA double-strand break induces colocalization between 53BP1 and S100A11 Bayer, Cathrin; Working group Biomolecular Photonics, Jena University 11 BIRC3 aberrations in chronic and B-cell acute lymphocytic leukemia patients Alhourani, Eyad; Institute of Human Genetics, Jena University 6

12 Relevance of ITIH5 for cervical carcinogenesis Dittmann, Jessica; Department of Gynecology, Jena University 13 MLL gene displaying an important molecular biomarker in acute leukaemia Othman, Moneeb A.K.; Institute of Human Genetics, Jena University 14 Detection of cervical carcinoma specific biomarkers by digital PCR Carow, Katrin; Department of Gynecology, Jena University 15 Abnormal expression of keratin 19 in lung carcinoma cell lines Wölfel, Cornelius; Institute of Pathology, Jena University 16 The role of SKAP in mitosis Vranesic, Anita Cindric; Institute of Biochemistry II, Jena University 17 Desmocollin 3 acts as a tumor suppressor through inhibiting PI3K/AKT/ MDM2 signaling in human colorectal cancer Ma, Yunxia; Institute of Pathology, Jena University POSTER SESSION 2: TUMOR DIAGNOSTIC AND THERAPY Chairs: Karlheinz Friedrich, Marcus Franz 18 Synthesis and biological behavior of O,S-chelating platinum(ii) and ruthenium(ii) complexes Hildebrandt, Jana; Institute of Inorganic and Analytical Chemistry, Jena University 19 FAS-Expression and survival as possible predictors in Human Glioblastoma? Vestergaard, Anita-Maria; AG Experimentelle Neuroonkologie, Klinik für Neurochirurgie, Jena University 7

20 EGCG induces cell death in human glioblastoma cell cultures Kögler, Christine; AG Experimentelle Neuroonkologie, Klinik für Neurochirurgie, Jena University 21 Novel cryptic rearrangements in adult B-cell precursor acute lymphoplastic leukemia involving MLL-gene Rittscher, Katharina; Institute of Human Genetics, Jena University 22 Tumour comorbidities in polycystic kidney disease Joorabchi, Samrand; Institute of Pathology, Jena University 23 Role of protein tyrosine phosphatases in the development of antiangiogenic therapy resistance in renal cell carcinoma Weiland, Anne; Institute for Molecular Cell Biology, Centre for Molecular Biomedicine (CMB), Jena University 24 Activated gamma/delta (γδ) T cell subsets after Salmonella stimulation Polasky, Christina; Institute of Molecular Pathogenesis, Friedrich- Loeffler-Institut (FLI) 25 Effect of the autophagy inhibitor chloroquine on gefitinib-resistant lung cancer cells and clinical relevance of autophagy-associated proteins Schnitzler, Kai-Leonie; Institute of Pathology, Jena University 26 Does epithelial to mesenchymal transition influence ALA accumulation in bladder cancer cells? Schleier, Richard; Institute of Pathology, Jena University 27 Heterogeneous response in cellular survival to MTX-MNP and hyperthermia exposure Pömpner, Nadine; Institute of Diagnostic and Interventional Radiology, Jena University 8

POSTER SESSION 3: TUMOR MICROENVIRONMENT AND EPIGENETIC REGULATION Chairs: Yuan Chen, Thomas Liehr 28 Serum-depletion affects protein trophoblast expression, resembling a tumoral adaptive switch Novoa-Herran, S; Placenta-Labor, Department of Obstetrics, Jena University 29 Methylation of specific genes in the course of cervical carcinogenesis: correlation to gene expression Eiselt, Juliane; Department of Gynecology, Jena University 30 Characterization of genes related to cisplatin-resistance in ovarian carcinoma cell lines Kritsch, Daniel; Department of Gynecology, Jena University 31 Influence of soy phytoestrogens on the uterine gene expression in mice Favaro, Rodolfo R; Placenta-Labor, Department of Obstetrics, Jena University 32 Coated superparamagnetic nickel nanorods affect cell vitality and intracellular signalling Schmidt, Ann-Kathrin; Abt. Hämatologie und Internistische Onkologie, Jena University 33 Raman spectroscopical investigations of senescence in human primary fibroblast cells Eberhardt, Katharina; Leibniz Institute of Photonic Technology (IPHT) Jena 34 Proteasomal decline in endothelial senescence Meçe, Odeta; Institute for Molecular Cell Biology, Centre for Molecular Biomedicine (CMB), Jena University 9

35 Angiogenesis is dependent on endothelial autophagy the role of AMPK Spengler, Katrin; Institut for Molecular Biology, Centre for Molecular Biomedicine (CMB), Jena University 36 Sodium-hydrogen exchanger NHE1 in endothelial cells regulates angiogenesis Kryeziu, Nderim; Institute for Molecular Cell Biology, Centre for Molecular Biomedicine (CMB); Jena University 37 Multicellular spheroids: A model for nanoparticle-cell interaction studies Demut, Johanna; Abt. Hämatologie und Internistische Onkologie, Jena University 15:00 ORAL PRESENTATIONS SESSION 2: TUMOR DIAGNOSTIC AND THERAPY Chairs: Ferdinand von Eggeling, Susanne Jennek 38 Functional analysis of CAMK2N1 and RUNX3 in Ovarian Carcinogenesis Heinze, Karolin; Department of Gynecology, Jena University 39 Measuring G protein signaling with a fluorescence-based membrane potential assay Günther, Thomas; Department of Pharmacology and Toxicology, Jena University 40 MALDI-Imaging: Mapping the cancer Hoffmann, Franziska; ENT Department, Jena University 41 Classification and prediction of liver cancer by Raman imaging Tolstik, Tatiana; Department of Internal Medicine IV, Division of Gastroenterology, Hepatology and Infectious Diseases, Jena University 10

17:00 Break 42 The expression of the protein lysine demethylases KDM1A, KDM2B, KDM5B and KDM6B is associated with poor clinical outcome in childhood acute lymphoblastic leukaemia Walter, Elisabeth; Department of Paediatric Haematology and Oncology, Children s ; Jena University 43 Inhibition of Breast Cancer Proliferation by Androgen Receptor Antagonists Luko, Katarina; Institute of Human Genetics, Jena University 44 Molecular analysis of CETCs in patients with hepatocellular carcinoma Berger, Tina; Abt. Hämatologie und Internistische Onkologie, Jena University 45 Detection of fetal fibronectin variants in patients serum: Implications for individualized targeted tumor therapy using armed antibodies Ospel, Johanna; Department of Internal Medicine I, Jena University 17:30 Dinner / Awards 11

Institute of Pathology, Jena University Prof. Dr. Iver Petersen, Prof. Dr. Alexander Berndt Phone: +49-(3641)-934002 Email: izkfonkologie@med.uni-jena.de 12